Amedica (AMDA) is Initiated by Ladenburg Thalmann to Buy , according to the research report released to the investors. The shares recommendation by the Brokerage Firm was released on Jan-5-2016.
Amedica Corporation has dropped 62.2% during the last 3-month period . Year-to-Date the stock performance stands at -85.16%.The company shares have dropped -87.36% from its 1 Year high price. On Jan 6, 2015, the shares registered one year high at $1.12 and the one year low was seen on Nov 13, 2015. The 50-Day Moving Average price is $0.12 and the 200 Day Moving Average price is recorded at $0.36.
Shares of Amedica Corporation (NASDAQ:AMDA) rose by 16.49% in the past week and 2.33% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 17.46% and the outperformance increases to 4.72% for the last 4 weeks.
Amedica Corporation (NASDAQ:AMDA) : On Thursday heightened volatility was witnessed in Amedica Corporation (NASDAQ:AMDA) which led to swings in the share price. The shares opened for trading at $0.11 and hit $0.12 on the upside , eventually ending the session at $0.1187, with a gain of 8.01% or 0.0088 points. The heightened volatility saw the trading volume jump to 4,344,551 shares. The 52-week high of the share price is $1.12 and the company has a market cap of $18 million. The 52-week low of the share price is at $0.09 .
Currently the company Insiders own 1% of Amedica Corporation shares according to the proxy statements. Institutional Investors own 10% of Amedica Corporation shares. During last six month period, the net percent change held by insiders has seen a change of 92.69%. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, Lombardi Ty, officer (VP Finance) of Amedica Corp, executed a transaction worth $10,000 on September 10, 2015. A total of 25,000 shares were purchased at an average price of $0.4. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Amedica Corporation (Amedica) is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a complementary line of non-silicon nitride spinal fusion products which allows us to provide surgeons and hospitals with a broader range of products. These products include three lines of spinal fusion devices and five types of orthobiologics, which are used by surgeons to help promote bone growth and fusion in spinal fusion procedures.